VIMTALABSNSEVimta Labs Limited· PharmaceuticalsMediumPositive
Announced Wed, 6 May · 16:59 IST

Vimta Labs Limited has informed the Exchange that Board of Directors at its meeting held on May 06, 2026, recommended Final Dividend of Rs. 2 per equity share.

Corporate Actions View source PDF

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹510.70
prior close
₹529.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+7.5+4.8+4.0+2.2+0.5-3.7-8.3-8.5-10.3-13.1-7.4+2.4+8.2
Up moveDown movePending
AI summary

Vimta Labs Limited's Board of Directors, in a meeting held on 6 May 2026, recommended a final dividend of Rs. 2 per equity share (100% of face value of Rs. 2) for the financial year 2025-26. The dividend is subject to shareholder approval at the ensuing Annual General Meeting. The record date for determining eligible shareholders is 18 June 2026, and the dividend will be paid on or before 8 July 2026. The company has its registered office in Hyderabad and its scrip is listed on both BSE (scrip code: 524394) and NSE (trading symbol: VIMTALABS).

Likely market impact

A Rs. 2 per share dividend signals consistent cash distribution to shareholders. With the stock trading around Rs. 200-250 (estimated), this represents a dividend yield of approximately 0.8-1%, which is modest and in line with typical small-cap lab testing companies reinvesting most profits for growth.